Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab Long-term Extension in Pediatric Crohn's Disease (IMAgINE 2)
NCT00686374Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- May 2008
- Primary completion
- Apr 2017
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of adalimumab in Crohn's disease, sponsored by AbbVie Inc.. Started May 2008; status: completed.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00686374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00686374.